Fendiline increases [Ca2+](i) in Madin Darby canine kidney (MDCK) cells by releasing internal Ca2+ followed by capacitative Ca2+ entry

Life Sciences

Volumn 66, Issue 11, 2000, Pages 1053-1062

  Jan, Chung Ren ^a   Tseng, Ching Jiunn ^a   Chen, Wei Chuan ^b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Ca2+; Capacitative Ca2+ entry; Fendiline; Fura 2; MDCK cells

Indexed keywords

CALCIUM; CALCIUM CHANNEL; CALMODULIN; FENDILINE; FURA 2; PHOSPHOLIPASE; THAPSIGARGIN; CALCIUM CHANNEL BLOCKING AGENT; ENZYME INHIBITOR;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL STRAIN; CONCENTRATION RESPONSE; DOG; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; FLUORESCENCE; INCUBATION TIME; NONHUMAN; ANIMAL; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; ION TRANSPORT; KIDNEY; METABOLISM;

ANIMALIA; CANIS FAMILIARIS;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL LINE; DOGS; ENZYME INHIBITORS; FENDILINE; ION TRANSPORT; KIDNEY; PHOSPHOLIPASES; THAPSIGARGIN;

EID: 0033621802     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00670-0     Document Type: Article

References (27)

1. R. Bayer and R. Mannhold, Pharmatherapeutica 5 103-136 (1987).
2. H. Nawrath, G. Klein, J. Rupp, J.W. Wegener and A. Shainberg, J. Pharmacol. Exp. Ther. 285 546-552 (1998).
3. O. Tripathi, W. Schreibmayer and H.A. Tritthart, Br. J. Pharmacol., 108 865-869 (1993).
4. F. Orosz, T.Y. Christova and J. Ovadi, Mol. Pharmacol. 33 678-682 (1988).
5. T. Nagao, S. Illiano and P.M. Vanhoutte, Br. J. Pharmacol. 107 382-386 (1992).
6. V.B. Schini and P.M. Vanhoutte, J. Pharmacol. Exp. Ther. 261 553-559 (1992).
7. R. Busse, A. Luckhoff, I. Winter, A. Mulsch and U. Pohl, N-S Arch. Pharmacol. 337 79-84 (1988).
8. C. Schlatterer and R. Schaloske, Biochem. J. 813 661-667 (1996).
9. A. Luckhoff, M. Bohnert and R. Busse. N-S. Arch. Pharmacol. 343 96-101 (1991).
10. C.R. Jan, C.M. Ho, S.N. Wu, J.K. Huang and C.J. Tseng, Life Sci. 62 533-540 (1998).
11. C.R. Jan, C.M. Ho, S.N. Wu and C.J. Tseng, Chin. J. Physiol. 41 59-64 (1998).
12. C.R. Jan, C.M. Ho, S.N. Wu and C.J. Tseng, Eur. J. Pharmacol. 35 219-233 (1998).
13. Jr. J.W. Putney and G.S.J. Bird, Cell 75 199-201 (1993).
14. C.R. Jan, C.M. Ho, S.N. Wu and C.J. Tseng, Life Sci. 64 259-267 (1999)
15. C.R. Jan, C.M. Ho, S.N. Wu and C.J. Tseng, Eur. J. Pharmacol. 365 111-117 (1999).
16. G. Grynkiewicz, M. Poenie and R.Y. Tsien, J. Biol. Chem. 260 3440-3450 (1985).
17. O. Thastrup, P.T. Cullen, B.K. Drobak, M.R. Hanley and A.P. Dawson, Proc. Natl. Acad. Sci. USA 87 2466-2470 (1990).
18. J.E. Merritt, R. Jocob and T.J. Hallam, J. Biol. Chem. 264 1522-1527 (1989).
19. C.R. Jan, C.M. Ho, S.N. Wu and CJ Tseng, Life Sci. 63 895-908 (1998).
20. C.R. Jan, C.M. Ho, S.N. Wu and C.J. Tseng, N-S Arch. Pharmacol. 359 92-101 (1999).
21. C.R. Jan, C.M. Ho, S.N. Wu and C.J. Tseng, Biochim Biophys Acta 1448:533-542 (1999).
22. W. Schreibmayer, O. Tripathi and H.A. Tritthart, Br. J Pharmacol. 106 151-156 (1992).
23. F. Lang and M. Paulmichl M, Kidney Int. 48 1200-1205 (1995).
24. A.K. Thompson, S.P. Mostafapour, L.C. Denlinger, J.E. Bleasdale and S.K. Fisher, J. Biol. Chem. 266 23856-23862 (1991).
25. M.D. Rosenthal, B.S. Vishwanath and R.C. Franson, J. Biol. Chem. 264 17069-17077 (1989).
26. M.M. Billah, S. Eckel, T.J. Mullmann, R.W. Egan and M.I. Siegel, Biochim. Biophys. Acta. 1001 1-8 (1989).
27. W.W. Lin, N-S Arch. Pharmacol. 352 679-684 (1995).